Screening of sterile OTC monograph drug products for microbial contamination

Ended Purchase Order Awarded Last action

Contract number
75F40124P00447
Awardee
Awarding agency
Obligated
$38,860

Award facts

Contract value 100% obligated
$38,860.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Hamilton, OH 45014, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 -$171,540
Original award $210,400

About this award

Written by GovTribe AI ·

The Food and Drug Administration awarded a purchase order to Element Materials Technology Holding USA Inc. for $38,860 on September 10, 2024, to screen sterile over-the-counter monograph drug products for microbial contamination as part of the FY26 UDO Initiative. Work is performed in Hamilton, Ohio, with an ultimate completion date of September 29, 2025. The order carries no set-aside designation and is priced on a firm fixed-price basis.

Quick answers

Who was awarded contract 75F40124P00447?

75F40124P00447 was awarded to Element Materials Technology Holding USA Inc. by Food and Drug Administration (Department of Health and Human Services) on September 10, 2024.

How much is contract 75F40124P00447 worth?

The government has obligated $38,860 on 75F40124P00447.

Was contract 75F40124P00447 competed?

The extent of competition for 75F40124P00447 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login